Visual Performance of Clareon Vivity and PureSee IOL

Who May Qualify: - Patients of any sex and race aged 50 years or older - Patients undergoing bilateral age-related cataract surgery with a lens opacity grade 3 or higher in the LOCS III grading scale - Willing to receive implantation of an EDOF IOL - Willing to sign the willing to sign a consent form and attend the study visits Who Should NOT Join This Trial: - Requirement of a spherical or toric power of the IOL to achieve emmetropia beyond the available range of either of the two lenses - The number of patients included with low astigmatism that require an equivalent to a T2 toric IOL will be capped to 10 patients/group - Irregular astigmatism - Contact lens wear in the previous 3 weeks before biometry - Moderate or severe ocular surface, corneal, macular or optic nerve disease that in opinion of the investigator precludes the desired functional results - History of previous refractive, cornea, retina or glaucoma surgery - Eyes with a clear lens demanding a refractive lens exchange - Amblyopia in any eye - Significant previous ocular trauma - Pregnancy - A systemic condition that, in the opinion of the investigator, precludes the reliable assessments required in the study (i.e., dementia) or participation in the study (i.e., severe mobility problems). Always talk to your doctor about whether this trial is right for you.